11/01/1980 - "Eleven strains of Chlamydia trachomatis were inhibited by 5 microgram of rosoxacin per ml, and each of seven Ureaplasma urealyticum strains was inhibited by 2 to 8 microgram of rosoxacin per ml. The results of these susceptibility studies, coupled with those of an earlier evaluation of the pharmacokinetics of rosoxacin, provide support for extending or undertaking clinical evaluations of this compound against infections with N. "
01/01/1982 - "It is concluded that rosoxacin can be of great usefulness in the epidemiological control of acute gonococcal infection, because of the lack of in vitro resistance to it, its minimal adverse effects, the low dose requirements, and the effectiveness of a single dose. "
11/01/1981 - "gonorrhaeae, required a minimal inhibitory concentration of less than or equal to 0.062 microgram/ml. Urethral or cervical infection with Chlamydia trachomatis coexisted with gonococcal infection in 14 (22%) of 63 patients and persisted in 7 of 10 patients treated with rosoxacin. "
01/01/1982 - "The results obtained in this study warrant further clinical trials for rosoxacin in the treatment of bacterial prostatitis and urinary infections."
01/01/1984 - "Thirty (97%) of 31 patients receiving rosoxacin were cured of their infection as were 25 (96%) of 26 patients who received the oral regimen of ampicillin plus probenecid. "
11/01/1981 - "Rosoxacin in doses of greater than or equal to 200 mg appears to be effective for single-dose treatment of uncomplicated gonorrhea, but further studies of its possible central nervous system toxicity are indicated."
11/01/1981 - "In a randomized, double-blind, dose-ranging study, single oral doses of rosoxacin were used to treat 126 patients with uncomplicated genital or anorectal gonorrhea. "
07/01/1988 - "[Further observations on the effect of rosoxacin in men with gonorrhea]."
05/01/1987 - "[Rosoxacin, a new oral antibiotic used selectively in the treatment of gonorrhea]."
07/12/1985 - "[Management of acute gonorrhea in males with Rosoxacin]."
08/01/1984 - "We concluded that rosoxacin at a dosage of 300 mg administered orally was fairly effective in the treatment of gonococcal urethritis in men caused by both PPNG and non-PPNG strains."
10/01/1990 - "Rosoxacin in the treatment of uncomplicated acute gonococcal urethritis."
02/01/1985 - "Only six (19%) of 31 patients treated with rosoxacin were free of urethritis after 10 days; Chlamydia trachomatis was reisolated from 12 (92%) of 13 patients who were chlamydia positive originally, and Ureaplasma urealyticum was reisolated from 12 (80%) of 15 patients who were ureaplasma positive originally. "
02/01/1985 - "Unsuccessful treatment of non-gonococcal urethritis with rosoxacin provides information on the aetiology of the disease."
08/01/1982 - "[Gonococcal urethritis--treatment with rosoxacin]."
07/01/1986 - "Administration of 150 mg of rosoxacin twice daily for 3 days is an effective regimen for the therapy of chancroid and is a reasonable alternative to other short-course regimens."
07/01/1986 - "One hundred seven men with Haemophilus ducreyi-positive chancroid were assigned to receive 300 mg of rosoxacin as a single dose or 150 mg twice daily for 3 days. "
07/01/1986 - "Clinical evaluation of rosoxacin for the treatment of chancroid."
|7.||Pipemidic Acid (Palin)
|10.||Penicillin G Procaine (Procaine, Benzylpenicillin)